Skip to Main Content

Paper Details

Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.
Genet Med
19
2018
Cancer, Human, clinically relevant genes, genes, patients, reduced coverage loci, reduced coverage regions
Author NameAffiliation
Christian J BuhayBaylor College of Medicine
Michael O DorschnerUW Medicine Center for Precision Diagnostics, University of Washington
Michael O DorschnerUW Medicine Center for Precision Diagnostics, University of Washington
Matthew S Lebo
Matthew S LeboBrigham & Women's Hospital and Harvard Medical School
Kevin M BowlingHudsonAlpha Institute for Biotechnology
Gregory M CooperHudsonAlpha Institute for Biotechnology
Gregory M CooperHudsonAlpha Institute for Biotechnology
Robert J LonigroUniversity of Michigan ann arbor
Robert J LonigroMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Christine BrennanUniversity of Michigan ann arbor
Christine BrennanMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Mauricio O CarneiroBroad Institute of MIT and Harvard
Lucia A HindorffNational Human Genome Research Institute, National Institutes of Health
Lucia A HindorffNational Human Genome Research Institute, National Institutes of Health
Dan R RobinsonUniversity of Michigan ann arbor
Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan Medical School ann arbor
Heidi L Rehm
Heidi L RehmBroad Institute of MIT and Harvard
Heidi L RehmBrigham & Women's Hospital and Harvard Medical School
Heidi L Rehm
Heidi L RehmBrigham & Women's Hospital and Harvard Medical School
Heidi L RehmBroad Institute of MIT and Harvard
Leslie G BieseckerNational Human Genome Research Institute, National Institutes of Health
Leslie G BieseckerNational Human Genome Research Institute, National Institutes of Health
Deborah A NickersonUniversity of Washington
Deborah A NickersonUniversity of Washington
Carolyn M HutterNational Human Genome Research Institute, National Institutes of Health
Carolyn M HutterNational Human Genome Research Institute, National Institutes of Health
Levi A GarrawayBroad Institute of MIT and Harvard
Levi A GarrawayHoward Hughes Medical Institute
Levi A GarrawayBrigham and Women's Hospital and Harvard Medical School
Levi A GarrawayCenter for Cancer Precision Medicine and Department of Medical Oncology, Dana-Farber Cancer Institute
Levi A GarrawayBroad Institute of MIT and Harvard
Levi A GarrawayCenter for Cancer Precision Medicine and Department of Medical Oncology, Dana-Farber Cancer Institute
Levi A GarrawayBrigham and Women's Hospital and Harvard Medical School
Levi A GarrawayHoward Hughes Medical Institute
Donna M MuznyBaylor College of Medicine
Donna M MuznyBaylor College of Medicine
Nikhil WagleBroad Institute of MIT and Harvard
Nikhil WagleCenter for Cancer Precision Medicine and Department of Medical Oncology, Dana-Farber Cancer Institute
Nikhil WagleBrigham and Women's Hospital and Harvard Medical School
Nikhil WagleBroad Institute of MIT and Harvard
Nikhil WagleCenter for Cancer Precision Medicine and Department of Medical Oncology, Dana-Farber Cancer Institute
Nikhil WagleBrigham and Women's Hospital and Harvard Medical School
  • 1 - 45

Datasets